- Home
- / Transition Bio
Transition Bio
Total Funding
$50 M
Transition Bio Summary
Company Summary
- Overview
- Transition Bio is a biotechnology company that provides technologies for biomolecular condensate analysis. It develops droplet microfluidic approaches and protein biophysics platforms to revolutionize condensate drug discovery.
- Type
- Private
- Status
- Active
- Founded
- 2020
- HQ
- Cambridge, MA, US | view all locations
- Website
- https://transitionbio.com
- Cybersecurity rating
Table of Contents
Key People
Martin Kulander, Chief Operating Officer
Thomas Knowles, Scientific Co-Founders
David A.Weitz, Scientific Co-Founders
LocationsView all
2 locations detected
Cambridge, MA HQ
United States
21 Erie St c
Cambridge, England
United Kingdom
Maxwell Building JJ Thompson Avenue